Wendy J. Levin

Dr Levin is a US-trained oncologist and haematologist with over 15 years’ industry experience in translational medicine and drug development, leading clinical development and medical affairs as well as supporting business development. She has provided strategic support for pre-IPO start-ups and Fortune 500 companies, led health authority and regulatory interactions, executed clinical advisory boards, provided clinical leadership for first-in-human studies to Phase 3 registration trials.